| Literature DB >> 9302756 |
E Wehmann1, J Herczeg, A Ballagi-Pordány, B Lomniczi.
Abstract
A region constituting 88% of the matrix gene of Newcastle disease virus vaccine strains LaSota and B-1 was amplified by reverse transcription-polymerase chain reaction. Amplified products of LaSota and B-1 strains derived from vaccine serials of different companies were digested with restriction enzymes MboI and HinfI. Strain characteristic cleavage site maps were obtained that allowed for a reliable and rapid differentiation between strains LaSota and B-1.Entities:
Mesh：
Substances：
Year: 1997 PMID： 9302756 DOI： 10.1016/s0264-410x(97)00057-1
Source DB: PubMed Journal: Vaccine ISSN： 0264-410X Impact factor: 3.641